Fibrinogen Market Growth Drivers by 2031
The Fibrinogen Market is expected to register a CAGR of 7.80% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report presents an analysis based on by Product Type (Heat Precipitation tests, Clotting methods, Immunoassays, DNA tests). The report further provides analysis based onEnd-user (Hospitals, Clinics, Diagnostic laboratories, Ambulatory care centers, Academics, Research Institutes). The global analysis is further broken-down at regional level and major countries. The market size and forecast at global, regional, and country levels for all the key market segments are covered under the scope. The report offers the value in USD for the above analysis and segments. The report provides key statistics on the market status of the key market players and offers market trends and opportunities.
Purpose of the ReportThe report Fibrinogen Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Fibrinogen Market Segmentation
Type- Heat Precipitation tests
- Clotting methods
- Immunoassays
- DNA tests;
- Hospitals
- Clinics
- Diagnostic laboratories
- Ambulatory care centers
- Academics
- Research Institutes
Strategic Insights
Fibrinogen Market Growth Drivers- Bleeding disorders, their rising incidence: Hemophilia, liver disorders, trauma is causing more demand for fibrinogen since, in addition to the functions associated with blood clotting, the role of fibrinogen used during the management of bleeding episodes or surgical bleeding complications is becoming broader, especially in hospitals and trauma centres. This has fuelled the growth of the fibrinogen market.
- Technological Advancement Relative to Blood Coagulation Therapy: The flow of the blood coagulation therapy advancements has also fuelled the growth of the market. Application of new production methods in improving the purification processes marshals formulating better product formulations with superior clinical performance in surgery, trauma, and critical care and hence increasing their usage and demand globally across healthcare settings.
- Increasing Number of Elderly People: The aging global population has been the other prime factor behind the fibrinogen market. Most old people are susceptible to chronic ailments, including bleeding disorders, vascular diseases, and complications from trauma. Since the elderly require far more surgical interventions and medical treatments, the demand for therapies based on fibrinogen in jammed places is expected to rise-adding growth in the market.
- Personalized Medicine Trend for Fibrinogen: The trend towards personalized medicine is popular among fibrinogen. The therapies can now be tailored according to the genomic background of an individual together with their unique coagulation requirements as a consequence of genomics' and biotechnology's advances. This further enables targeted, efficient, and effective fibrinogen therapy for improved patient outcome especially with bleeding disorders and surgical interventions.
- Recombinant Fibrinogen Development: Recombinant fibrinogen is coming up as an emerging trend taking over all carbohydrate products derived from humans for blood clotting therapies. These synthetic fibrinogen products are user-friendly, they lower the risk of disease transmission because they are not derived from human and respond to the needs of people who are looking up to a greener and ethical alternative, thus paving the way for world adoption in hospitals and medical treatments.
- Increasing Adoption of Point-of-Care Testing: Point-of-care testing makes the revolution of the fibrinogen market. Devices that quickly assess fibrinogen levels in emergency and trauma situations will allow medical personnel to make rapid, accurate decisions about whether to supplement with fibrinogen. This trend supports patient care by ensuring timely treatment within critical seconds for bleeding control.
- Advancements in Biotechnology for Fibrinogen Production: Biotechnology is revolutionizing the production of fibrinogen through cell culture and gene editing. All of these are leading towards more economical and effective high-quality fibrinogen products. Best Production Practices allow the manufacturer to satisfy the increasing demand for fibrinogen therapies in hospitals and clinics and thus expand the overall market.
- Collaborations with Blood Banks and Plasma Centers: If the manufacturer partners with blood banks and plasma centers for the continuous uninterrupted supply of fibrinogen, it offers a unique opportunity for the manufacturer. By embedding the company's products in the blood transfusion and plasma collection systems, long-term contracts are expected to be formed, bringing large availability and use of these products in hospitals and clinics.
- Combination Action Fibrinogen Medications Development: This is where Innovation can be through single product dual-action fibrinogen therapies where the therapies have clotting factors and fibrinogen combined into one product. Such therapies would result in improved bleeding control during surgical or trauma recovery in patients. Such combination therapies would appeal to providers who promote their utilization by offering more efficient, yet comprehensive, solutions in clotting.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Fibrinogen Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Fibrinogen Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORKHave a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The final report will duly include market size and projection estimates for all the segments from 2021 to 2031, along with a revenue share and compound annual growth rate (%) for the regional
/
country-wise market wherein 2021-2022 are the historic years, 2023 is considered to be the base year, and the forecast will be provided till 2031, along with CAGR (%)
The North America region accounts for highest revenue share Fibrinogen market
Asia Pacific is estimated to grow at the highest CAGR over the forecast year (2023 - 2031)
Rising Incidence of Sports Injuries is the major factors boosting the Fibrinogen market growth
F.Hoffmann-La Roche Ltd Abbott Seimens Coagusense, Inc. HemoSonics Microsystems Instrumentation Laboratory India Pvt.Ltd. SenGenix RUSNANO Group are the major companies operating in the Fibrinogen market
The market is expected to grow at a CAGR of 5.5%
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Fibrinogen Market - By Type
1.3.2 Fibrinogen Market - By End-user
1.3.3 Fibrinogen Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. FIBRINOGEN MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. FIBRINOGEN MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. FIBRINOGEN MARKET - GLOBAL MARKET ANALYSIS
6.1. FIBRINOGEN - GLOBAL MARKET OVERVIEW
6.2. FIBRINOGEN - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING
7. FIBRINOGEN MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. HEAT PRECIPITATION TESTS
7.3.1. Overview
7.3.2. Heat Precipitation tests Market Forecast and Analysis
7.4. CLOTTING METHODS
7.4.1. Overview
7.4.2. Clotting methods Market Forecast and Analysis
7.5. IMMUNOASSAYS
7.5.1. Overview
7.5.2. Immunoassays Market Forecast and Analysis
7.6. DNA TESTS
7.6.1. Overview
7.6.2. DNA tests Market Forecast and Analysis
8. FIBRINOGEN MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
8.1. OVERVIEW
8.2. END-USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. DIAGNOSTIC LABORATORIES
8.5.1. Overview
8.5.2. Diagnostic laboratories Market Forecast and Analysis
8.6. AMBULATORY CARE CENTERS
8.6.1. Overview
8.6.2. Ambulatory care centers Market Forecast and Analysis
8.7. ACADEMICS
8.7.1. Overview
8.7.2. Academics Market Forecast and Analysis
8.8. RESEARCH INSTITUTES
8.8.1. Overview
8.8.2. Research Institutes Market Forecast and Analysis
9. FIBRINOGEN MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Fibrinogen Market Overview
9.1.2 North America Fibrinogen Market Forecasts and Analysis
9.1.3 North America Fibrinogen Market Forecasts and Analysis - By Type
9.1.4 North America Fibrinogen Market Forecasts and Analysis - By End-user
9.1.5 North America Fibrinogen Market Forecasts and Analysis - By Countries
9.1.5.1 United States Fibrinogen Market
9.1.5.1.1 United States Fibrinogen Market by Type
9.1.5.1.2 United States Fibrinogen Market by End-user
9.1.5.2 Canada Fibrinogen Market
9.1.5.2.1 Canada Fibrinogen Market by Type
9.1.5.2.2 Canada Fibrinogen Market by End-user
9.1.5.3 Mexico Fibrinogen Market
9.1.5.3.1 Mexico Fibrinogen Market by Type
9.1.5.3.2 Mexico Fibrinogen Market by End-user
9.2. EUROPE
9.2.1 Europe Fibrinogen Market Overview
9.2.2 Europe Fibrinogen Market Forecasts and Analysis
9.2.3 Europe Fibrinogen Market Forecasts and Analysis - By Type
9.2.4 Europe Fibrinogen Market Forecasts and Analysis - By End-user
9.2.5 Europe Fibrinogen Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Fibrinogen Market
9.2.5.1.1 Germany Fibrinogen Market by Type
9.2.5.1.2 Germany Fibrinogen Market by End-user
9.2.5.2 France Fibrinogen Market
9.2.5.2.1 France Fibrinogen Market by Type
9.2.5.2.2 France Fibrinogen Market by End-user
9.2.5.3 Italy Fibrinogen Market
9.2.5.3.1 Italy Fibrinogen Market by Type
9.2.5.3.2 Italy Fibrinogen Market by End-user
9.2.5.4 United Kingdom Fibrinogen Market
9.2.5.4.1 United Kingdom Fibrinogen Market by Type
9.2.5.4.2 United Kingdom Fibrinogen Market by End-user
9.2.5.5 Russia Fibrinogen Market
9.2.5.5.1 Russia Fibrinogen Market by Type
9.2.5.5.2 Russia Fibrinogen Market by End-user
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Fibrinogen Market Overview
9.3.2 Asia-Pacific Fibrinogen Market Forecasts and Analysis
9.3.3 Asia-Pacific Fibrinogen Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Fibrinogen Market Forecasts and Analysis - By End-user
9.3.5 Asia-Pacific Fibrinogen Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Fibrinogen Market
9.3.5.1.1 Australia Fibrinogen Market by Type
9.3.5.1.2 Australia Fibrinogen Market by End-user
9.3.5.2 China Fibrinogen Market
9.3.5.2.1 China Fibrinogen Market by Type
9.3.5.2.2 China Fibrinogen Market by End-user
9.3.5.3 India Fibrinogen Market
9.3.5.3.1 India Fibrinogen Market by Type
9.3.5.3.2 India Fibrinogen Market by End-user
9.3.5.4 Japan Fibrinogen Market
9.3.5.4.1 Japan Fibrinogen Market by Type
9.3.5.4.2 Japan Fibrinogen Market by End-user
9.3.5.5 South Korea Fibrinogen Market
9.3.5.5.1 South Korea Fibrinogen Market by Type
9.3.5.5.2 South Korea Fibrinogen Market by End-user
9.3.5.6 Rest of Asia-Pacific Fibrinogen Market
9.3.5.6.1 Rest of Asia-Pacific Fibrinogen Market by Type
9.3.5.6.2 Rest of Asia-Pacific Fibrinogen Market by End-user
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Fibrinogen Market Overview
9.4.2 Middle East and Africa Fibrinogen Market Forecasts and Analysis
9.4.3 Middle East and Africa Fibrinogen Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Fibrinogen Market Forecasts and Analysis - By End-user
9.4.5 Middle East and Africa Fibrinogen Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Fibrinogen Market
9.4.5.1.1 South Africa Fibrinogen Market by Type
9.4.5.1.2 South Africa Fibrinogen Market by End-user
9.4.5.2 Saudi Arabia Fibrinogen Market
9.4.5.2.1 Saudi Arabia Fibrinogen Market by Type
9.4.5.2.2 Saudi Arabia Fibrinogen Market by End-user
9.4.5.3 U.A.E Fibrinogen Market
9.4.5.3.1 U.A.E Fibrinogen Market by Type
9.4.5.3.2 U.A.E Fibrinogen Market by End-user
9.4.5.4 Rest of Middle East and Africa Fibrinogen Market
9.4.5.4.1 Rest of Middle East and Africa Fibrinogen Market by Type
9.4.5.4.2 Rest of Middle East and Africa Fibrinogen Market by End-user
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Fibrinogen Market Overview
9.5.2 South and Central America Fibrinogen Market Forecasts and Analysis
9.5.3 South and Central America Fibrinogen Market Forecasts and Analysis - By Type
9.5.4 South and Central America Fibrinogen Market Forecasts and Analysis - By End-user
9.5.5 South and Central America Fibrinogen Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Fibrinogen Market
9.5.5.1.1 Brazil Fibrinogen Market by Type
9.5.5.1.2 Brazil Fibrinogen Market by End-user
9.5.5.2 Argentina Fibrinogen Market
9.5.5.2.1 Argentina Fibrinogen Market by Type
9.5.5.2.2 Argentina Fibrinogen Market by End-user
9.5.5.3 Rest of South and Central America Fibrinogen Market
9.5.5.3.1 Rest of South and Central America Fibrinogen Market by Type
9.5.5.3.2 Rest of South and Central America Fibrinogen Market by End-user
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL FIBRINOGEN MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. FIBRINOGEN MARKET, KEY COMPANY PROFILES
12.1. F.HOFFMANN-LA ROCHE LTD
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ABBOTT
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SEIMENS
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. COAGUSENSE,INC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. HEMOSONICS
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MICROSYSTEMS
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. INSTRUMENTATION LABORATORY INDIA PVT.LTD
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SENGENIX
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. RUSNANO GROUP
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. COAGULATION SCIENCES LLC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies
- F.Hoffmann-La Roche Ltd
- Abbott
- Seimens
- Coagusense, Inc.
- HemoSonics
- Microsystems
- Instrumentation Laboratory India Pvt.Ltd.
- SenGenix
- RUSNANO Group
- Coagulation Sciences LLC
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.